Pharmacogenetics and safety parameters for platelet P2Y12 receptor antagonists.
Publication
, Journal Article
Becker, RC
Published in: J Thromb Thrombolysis
November 2009
Duke Scholars
Published In
J Thromb Thrombolysis
DOI
EISSN
1573-742X
Publication Date
November 2009
Volume
28
Issue
4
Start / End Page
513 / 514
Location
Netherlands
Related Subject Headings
- Receptors, Purinergic P2Y12
- Receptors, Purinergic P2
- Purinergic P2 Receptor Antagonists
- Platelet Aggregation Inhibitors
- Pharmacogenetics
- Humans
- Hemorrhage
- Cardiovascular System & Hematology
- Animals
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Becker, R. C. (2009). Pharmacogenetics and safety parameters for platelet P2Y12 receptor antagonists. J Thromb Thrombolysis, 28(4), 513–514. https://doi.org/10.1007/s11239-009-0385-4
Becker, Richard C. “Pharmacogenetics and safety parameters for platelet P2Y12 receptor antagonists.” J Thromb Thrombolysis 28, no. 4 (November 2009): 513–14. https://doi.org/10.1007/s11239-009-0385-4.
Becker RC. Pharmacogenetics and safety parameters for platelet P2Y12 receptor antagonists. J Thromb Thrombolysis. 2009 Nov;28(4):513–4.
Becker, Richard C. “Pharmacogenetics and safety parameters for platelet P2Y12 receptor antagonists.” J Thromb Thrombolysis, vol. 28, no. 4, Nov. 2009, pp. 513–14. Pubmed, doi:10.1007/s11239-009-0385-4.
Becker RC. Pharmacogenetics and safety parameters for platelet P2Y12 receptor antagonists. J Thromb Thrombolysis. 2009 Nov;28(4):513–514.
Published In
J Thromb Thrombolysis
DOI
EISSN
1573-742X
Publication Date
November 2009
Volume
28
Issue
4
Start / End Page
513 / 514
Location
Netherlands
Related Subject Headings
- Receptors, Purinergic P2Y12
- Receptors, Purinergic P2
- Purinergic P2 Receptor Antagonists
- Platelet Aggregation Inhibitors
- Pharmacogenetics
- Humans
- Hemorrhage
- Cardiovascular System & Hematology
- Animals
- 3202 Clinical sciences